The Fatigue Symptom Inventory: a systematic review of its psychometric properties
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Purpose Fatigue is one of the most common symptoms experienced by persons with chronic illness, including cancer. The effective management of fatigue hinges in part on the accuracy and reliability of its measurement. The purpose of this study was to review and characterize the use of the 14-item Fatigue Symptom Inventory (FSI) in published studies and to evaluate the available evidence for its psychometric properties. Methods A systematic review of the literature identified 55 studies reporting results for the FSI. Data were analyzed to characterize internal consistency reliability of multi-item FSI scales and test-retest reliability. Correlation coefficients were summarized to characterize concurrent, convergent, and divergent validity. Standardized effect sizes were calculated to characterize the discriminative validity of the FSI and its sensitivity to change. Results Sample sizes across studies ranged from 9-1,756. Approximately half of the samples consisted exclusively of females. Alpha coefficients for multi-item scales ranged from 0.84-0.96. Most items demonstrated low to moderate test-retest correlations. Correlations with other fatigue measures ranged from 0.41-0.86. Correlations with depression and anxiety measures were positive (range = 0.23-0.76). Correlations with measures of vitality and vigor were negative (range = -0.28 to -0.77). Effect sizes for discriminative validity and sensitivity to change ranged from small to medium and from small to large, respectivel…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Weassessed fatigue-related interference with the validated 7-item interference scale of the Fatigue Symptom Inventory (FSI) [14,29].”
From Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue (2023) · cites this paper as [29]
In the citing paper
“This study used the FSI–I subscale to test the fatigue interference. The subscale has shown good reliability and validity.62”
In the citing paper
“In a review of FSI studies, effect sizes for responsiveness to change ranged from small to large in behavioral and disease treatment trials with cancer patients [22].”
From Comparative responsiveness and minimally important difference of fatigue symptom inventory (FSI) scales and the FSI-3 in trials with cancer survivors (2022) · cites this paper as [22]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Smets, E. M. A., Garssen, B., Bonke, B., & De Haes, J. C. J. M. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)00125-o · Cited by 3,613
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,692
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00274-6 · Cited by 1,964 · cited 2×
“Examples of multidimensional measures include the Revised Piper Fatigue Scale [60], the Functional Assessment of Cancer Therapy-Fatigue Scale [77], and the Multidimensional Fatigue Inventory [69].”
MethodMethods for assessing responsiveness
Husted, J. A., Cook, R. J., Farewell, V. T., & Gladman, D. D. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00206-1 · Cited by 1,471 · cited 1×
“A standardized effect size [36] using baseline and follow-up scores and the standard deviation of baseline scores was calculated to characterize the sensitivity of the FSI to change.”
MethodThe revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer.
Piper, B. F., Dibble, S. L., Dodd, M. J., Weiss, M. C., Slaughter, R. E., & Paul, S. M. (1998) · PubMed · Cited by 1,025
de Haes, J., van Knippenberg, F., & Neijt, J. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.434 · Cited by 902 · cited 2×
“Examples of unidimensional measures include a single item embedded in a symptom checklist such as the Symptom Distress Scale [53] or the Rotterdam Symptom Checklist [17], the 7-item Fatigue Scale of the Profile of Mood States [54], and the Brief Fatigue Inventory [55].”
BackgroundMethodCancer-related fatigue: the scale of the problem
Hofman, M., Ryan, J. L., Figueroa-Moseley, C. D., Jean-Pierre, P., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-4 · Cited by 895 · cited 1×
“It is a common symptom of many diseases; evidence suggests it is one of the most common and distressing symptoms experienced by cancer patients [34, 56, 61, 75] and may persist for years following cancer treatment [6, 9, 56].”
BackgroundDittner, A. J., Wessely, S. C., & Brown, R. G. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00371-4 · Cited by 856 · cited 3×
“While several reviews [18, 44, 57, 73] have commented on the psychometric properties of fatigue measures in chronic illness, including cancer, the psychometric data provided in these reviews generally have been limited to the original studies on the development and validation of the measures.”
BackgroundResultAhles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736 · cited 2×
“Results We identified 55 articles published between the initial publication of the FSI and November 2009 that reported results on the administration of the FSI (see Table 1) [1–5, 7, 8, 10–13, 15, 16, 19–31, 35, 37, 39–43, 45, 46, 48–52, 58, 59, 62–68, 70–72, 74, 76, 78].”
BackgroundFatigue in long‐term breast carcinoma survivors: A longitudinal investigation
Bower, J. E., Ganz, P. A., Desmond, K. A., Bernaards, C., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2006) · Cancer · doi:10.1002/cncr.21671 · Cited by 694 · cited 2×
“Two studies did not specifically identify the FSI items or scales used [9, 26].”
BackgroundInfluentialFatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors
Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200207000-00010 · Cited by 540 · cited 2×
“Results We identified 55 articles published between the initial publication of the FSI and November 2009 that reported results on the administration of the FSI (see Table 1) [1–5, 7, 8, 10–13, 15, 16, 19–31, 35, 37, 39–43, 45, 46, 48–52, 58, 59, 62–68, 70–72, 74, 76, 78].”
BackgroundHann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K., Greenberg, H., & Lyman, G. H. (1998) · Quality of Life Research · doi:10.1023/a:1024929829627 · Cited by 525 · cited 14×
“Among the studies reporting associations with the CES-D, for example, correlation coefficients range from 0.34–0.76.”
BackgroundMethodSelf-citationFatigue and the cancer experience: the state of the knowledge.
Winningham, M. L., Nail, L. M., Burke, M., Brophy, L., Cimprich, B., Jones, L. S., Pickard-Holley, S., Rhodes, V. A., Pierre, B. S., & Beck, S. L. (1994) · PubMed · Cited by 522
Hann (1998) · Quality of Life Research · doi:10.1023/a:1008842517972 · Cited by 500
Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.
Broeckel, J. A., Jacobsen, P. B., Horton, J., Balducci, L., & Lyman, G. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1689 · Cited by 474 · cited 1×
“Results We identified 55 articles published between the initial publication of the FSI and November 2009 that reported results on the administration of the FSI (see Table 1) [1–5, 7, 8, 10–13, 15, 16, 19–31, 35, 37, 39–43, 45, 46, 48–52, 58, 59, 62–68, 70–72, 74, 76, 78].”
BackgroundSelf-citationWhitehead, L. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.08.019 · Cited by 451 · cited 3×
“[73] Interference Interference score=0.”
BackgroundCancer-related fatigue: A critical appraisal
Prue, G., Rankin, J., Allen, J., Gracey, J., & Cramp, F. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.026 · Cited by 407 · cited 5×
“Shun et al. [ 61 ] GRS with sum of severity, frequency, interference (0.41)”
BackgroundMethodInfluentialAdult cancer survivors: How are they faring?
Baker, F., Denniston, M., Smith, T., & West, M. M. (2005) · Cancer · doi:10.1002/cncr.21488 · Cited by 398
Further validation of the multidimensional fatigue symptom inventory-short form
Stein, K. D., Jacobsen, P. B., Blanchard, C. M., & Thors, C. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.06.003 · Cited by 385 · cited 5×
“The measure was further validated in a study of males and females with a variety of different cancer diagnoses [ 70 ].”
BackgroundMethodResultSelf-citationEspie, C. A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L. M., White, C. A., Douglas, N. J., Engleman, H. M., Kelly, H.-L., & Paul, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9006 · Cited by 383 · cited 3×
“Five studies reported results in the context of nonpharmacological interventions designed to ameliorate symptoms that included fatigue [15, 22, 30, 51, 74].”
MethodResultAhles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003) · Psycho-Oncology · doi:10.1002/pon.742 · Cited by 357 · cited 1×
“The FSI has also been shown to be positively correlated with measures of symptom burden [3, 29] and self-reported cognitive impairment [37, 63].”
Fatigue in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Jacobsen, P. B., Hann, D. M., Azzarello, L. M., Horton, J., Balducci, L., & Lyman, G. H. (1999) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00082-2 · Cited by 355 · cited 1×
“Six studies included cancer patients undergoing cancer treatment, including chemotherapy, radiotherapy, and autologous stem cell transplantation; four of these provided data sufficient for us to calculate effect sizes for FSI severity items, frequency items, and the interference scale [4, 25, 42, 43].”
BackgroundSelf-citationCognitive function in breast cancer patients prior to adjuvant treatment
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9686-5 · Cited by 345 · cited 1×
“One of these studies did not include information about the specific FSI items used [2].”
BackgroundSymptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease
McCorkle, R., & Quint-Benoliel, J. (1983) · Social Science & Medicine · doi:10.1016/0277-9536(83)90348-9 · Cited by 329 · cited 3×
“[53] FACIT-F with fatigue severity (−0.”
BackgroundA systematic review of the scales used for the measurement of cancer-related fatigue (CRF)
Minton, O., & Stone, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn537 · Cited by 323 · cited 4×
“One review [57] noted that data are also lacking with respect to Support Care Cancer”
BackgroundResultInfluentialInflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
Bower, J. E., Ganz, P. A., Tao, M. L., Hu, W., Belin, T. R., Sepah, S., Cole, S., & Aziz, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2584 · Cited by 315 · cited 1×
“Results We identified 55 articles published between the initial publication of the FSI and November 2009 that reported results on the administration of the FSI (see Table 1) [1–5, 7, 8, 10–13, 15, 16, 19–31, 35, 37, 39–43, 45, 46, 48–52, 58, 59, 62–68, 70–72, 74, 76, 78].”
BackgroundMeasurement of fatigue in cancer patients: further validation of the fatigue symptom inventory
Hann, D. M., Denniston, M. M., & Baker, F. (2000) · Quality of Life Research · doi:10.1023/a:1008900413113 · Cited by 258 · cited 8×
“Among the studies reporting associations with the CES-D, for example, correlation coefficients range from 0.34–0.76.”
MethodInfluentialAssessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales
Hjollund, N. H., Andersen, J. H., & Bech, P. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-12 · Cited by 224
How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature
Minton, O., & Stone, P. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9831-1 · Cited by 192 · cited 2×
“It is a common symptom of many diseases; evidence suggests it is one of the most common and distressing symptoms experienced by cancer patients [34, 56, 61, 75] and may persist for years following cancer treatment [6, 9, 56].”
BackgroundMonk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179 · cited 3×
“[57] Mix of cancer types Completed allogeneic or autologous hematopoietic stem cell transplant 6 or 12 months previously Evaluate FACT-Cog and determine relationship of cognitive complaints to quality of life 101 patients 56% male, 44% female 52.67 (12.18) Cross-sectional English Not reported Jacobsen et al. [ 58 ] Br…”
BackgroundInfluentialAssessment of Cancer-Related Fatigue: Implications for Clinical Diagnosis and Treatment
Jean-Pierre, P., Figueroa-Moseley, C. D., Kohli, S., Fiscella, K., Palesh, O. G., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-11 · Cited by 165 · cited 5×
“depends on several considerations [18, 44, 73].”
BackgroundResultInfluentialCourse of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer
Donovan, K. A., Jacobsen, P. B., Andrykowski, M. A., Winters, E. M., Balducci, L., Malik, U., Kenady, D., & McGrath, P. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.01.012 · Cited by 162 · cited 3×
“[19] Active treatment patients versus noncancer controls: most (−0.”
BackgroundSelf-citationAndrykowski, M. A., Schmidt, J. E., Salsman, J. M., Beacham, A. O., & Jacobsen, P. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.024 · Cited by 148 · cited 4×
“[2 5] B re as t ca nc er C om pl et ed ch em ot he ra py”
BackgroundSelf-citationIdentifying clinically meaningful fatigue with the fatigue symptom inventory
Donovan, K. A., Jacobsen, P. B., Small, B. J., Munster, P. N., & Andrykowski, M. A. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.11.013 · Cited by 144 · cited 4×
“These approaches included calculating a mean score across all four of the fatigue severity items [21], calculating a mean score across the most, least, and average fatigue severity items [20], creating a fatigue score ranging from 0–127 by summing the first 13 FSI items [59], and creating an index score with a value b…”
BackgroundMethodSelf-citationImpact of Hot Flashes on Quality of Life Among Postmenopausal Women Being Treated for Breast Cancer
Stein, K., Jacobsen, P. B., Hann, D. M., Greenberg, H., & Lyman, G. H. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00142-1 · Cited by 132 · cited 1×
“[ 71 ] Breast or prostate cancer Before, during and after radiotherapy Examine relationship of proinflammatory biomarkers to fatigue during radiotherapy 48 patients 42% male,%58 female Breast cancer 57.1 (29–75), prostate 70.6 (54–79) Longitudinal English Severity, frequency”
BackgroundSelf-citationCognitive functioning in breast cancer survivors: A controlled comparison
Jim, H. S. L., Donovan, K. A., Small, B. J., Andrykowski, M. A., Munster, P. N., & Jacobsen, P. B. (2009) · Cancer · doi:10.1002/cncr.24192 · Cited by 128 · cited 2×
“[44] interference Passik and Kirsh [45] Sum of severity, frequency, interference Wilson et al.”
BackgroundSelf-citationRelationship of Catastrophizing to Fatigue Among Women Receiving Treatment for Breast Cancer.
Jacobsen, P. B., Andrykowski, M. A., & Thors, C. L. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.2.355 · Cited by 123 · cited 1×
“[39] From prior to chemotherapy cycle 1 to after chemotherapy cycle 3: average (0.”
BackgroundSelf-citationWilson, R. W., Jacobsen, P. B., & Fields, K. K. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704815 · Cited by 121 · cited 3×
“Five studies reported results in the context of nonpharmacological interventions designed to ameliorate symptoms that included fatigue [15, 22, 30, 51, 74].”
BackgroundMethodResultSelf-citationAssessment of Fatigue in Cancer Patients
Jacobsen, P. B. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh010 · Cited by 121 · cited 2×
“[38] Interference Interference score range=0.”
BackgroundSelf-citationUtility of a cognitive-behavioral model to predict fatigue following breast cancer treatment.
Donovan, K. A., Small, B. J., Andrykowski, M. A., Munster, P., & Jacobsen, P. B. (2007) · Health Psychology · doi:10.1037/0278-6133.26.4.464 · Cited by 118 · cited 5×
“93) [21] and the mean of three severity items (0.”
BackgroundMethodSelf-citationHann, D. M., Jacobsen, P. B., Martin, S. C., Kronish, L. E., Azzarello, L. M., & Fields, K. K. (1997) · Supportive Care in Cancer · doi:10.1007/bf01681961 · Cited by 117 · cited 3×
“Jacobsen et al. [ 28 ] Interference Jacobsen et al. [29] Interference”
BackgroundMethodSelf-citationJacobs, S. R., Jacobsen, P. B., Booth‐Jones, M., Wagner, L. I., & Anasetti, C. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.06.011 · Cited by 115 · cited 4×
“Sadler et al. [35] Interference Respini et al. [ 37 ] Interference”
BackgroundResultSelf-citationThe prevalence and moderators of fatigue in people who have been successfully treated for cancer
Young, K. E., & White, C. A. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2005.03.011 · Cited by 114 · cited 1×
“Although many studies reportedly administered the complete 14-item FSI, only one study reported results for the 14th item assessing the daily pattern of fatigue [78].”
Henderson, D. C., Kunkel, L., Nguyen, D. D., Borba, C. P., Daley, T. B., Louie, P. M., Freudenreich, O., Cather, C., Evins, A. E., & Goff, D. C. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00612.x · Cited by 114 · cited 2×
“The FSI was also administered in single-arm trials [31, 51, 74] and randomized controlled trials [17, 21].”
MethodResultFatigue and Functional Dependence in Older Cancer Patients
Luciani, A., Jacobsen, P. B., Extermann, M., Foa, P., Marussi, D., Overcash, J. A., & Balducci, L. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31816d915f · Cited by 108 · cited 1×
“There were few studies of older cancer patients; only four reported a mean/median age greater than 65 years of age [16, 46, 52, 62].”
BackgroundSelf-citationCarpenter, K. M., Andersen, B. L., Fowler, J. M., & Maxwell, G. L. (2008) · Archives of Sexual Behavior · doi:10.1007/s10508-008-9349-6 · Cited by 104 · cited 6×
“Among the studies reporting associations with the CES-D, for example, correlation coefficients range from 0.34–0.76.”
MethodInfluentialPreliminary Evaluation of a Clinical Syndrome Approach to Assessing Cancer-Related Fatigue
Sadler, I. J., Jacobsen, P. B., Booth‐Jones, M., Belanger, H. G., Weitzner, M. A., & Fields, K. K. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00388-3 · Cited by 102 · cited 1×
“[64] Cognitive behavioral intervention group versus treatment as usual from baseline to post-test: interference (−0.”
MethodSelf-citationJacobsen, P. B., Garland, L. L., Booth‐Jones, M., Donovan, K. A., Thors, C. L., Winters, E. M., & Grendys, E. C. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.11.002 · Cited by 102 · cited 2×
“[42] Interference Interference score=0.”
BackgroundSelf-citationThe prevalence and correlates of fatigue in older cancer patients
Respini, D., Jacobsen, P. B., Thors, C. L., Tralongo, P., & Balducci, L. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00176-2 · Cited by 99 · cited 5×
“[62] Patient stage 0 versus noncancer control: fatigue (0.”
BackgroundMethodSelf-citationKarvinen, K. H., Courneya, K. S., North, S. A., & Venner, P. M. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0680 · Cited by 95 · cited 2×
“There were few studies of older cancer patients; only four reported a mean/median age greater than 65 years of age [16, 46, 52, 62].”
BackgroundKumar, N. B., Allen, K. A., Riccardi, D., Bercu, B. B., Cantor, A. B., Minton, S., Balducci, L., & Jacobsen, P. B. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010708.99455.e1 · Cited by 92
Self-citationHann, D. M., Garovoy, N. D., Finkelstein, B., Jacobsen, P. B., Azzarello, L. M., & Fields, K. K. (1999) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00007-x · Cited by 91 · cited 2×
“Six studies included cancer patients undergoing cancer treatment, including chemotherapy, radiotherapy, and autologous stem cell transplantation; four of these provided data sufficient for us to calculate effect sizes for FSI severity items, frequency items, and the interference scale [4, 25, 42, 43].”
BackgroundSelf-citationCharacteristics and correlates of cognitive functioning following bone marrow transplantation
Booth‐Jones, M., Jacobsen, P. B., RANSOM, S. D., & Soety, E. M. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705108 · Cited by 90 · cited 2×
“[2 7] B re as t ca nc er S ch ed ul ed fo r au to lo go us”
BackgroundSelf-citationHormes, J. M., Lytle, L. A., Gross, C. R., Ahmed, R. L., Troxel, A. B., & Schmitz, K. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2661 · Cited by 89 · cited 2×
“[ 35 ] Mix of cancer types Between 5 and 12 months post-bone marrow transplantation Evaluate clinical syndrome approach to assessing cancer-related fatigue 51 patients 25% male, 75% female 48 (9) (23–63) Cross-sectional English Severity, frequency, interference”
BackgroundKirsh, K. L., Passik, S. D., Holtsclaw, E., Donaghy, K. B., & Theobald, D. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00350-5 · Cited by 83 · cited 1×
“[48] Mean of severity, one frequency item, interference Losito et al.”
BackgroundComparing relaxation training and cognitive-behavioral group therapy for women with breast cancer
Cohen, M., & Fried, G. (2007) · Research on Social Work Practice · doi:10.1177/1049731506293741 · Cited by 83 · cited 7×
“Two studies did not report gender characteristics of the sample [15, 16].”
BackgroundMethodResultInfluentialStress and Quality of Life in Breast Cancer Recurrence: Moderation or Mediation of Coping?
Yang, H.-C., Brothers, B. M., & Andersen, B. L. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-008-9016-0 · Cited by 81 · cited 1×
“Results We identified 55 articles published between the initial publication of the FSI and November 2009 that reported results on the administration of the FSI (see Table 1) [1–5, 7, 8, 10–13, 15, 16, 19–31, 35, 37, 39–43, 45, 46, 48–52, 58, 59, 62–68, 70–72, 74, 76, 78].”
BackgroundSimonelli, L. E., Fowler, J., Maxwell, G. L., & Andersen, B. L. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-008-9029-8 · Cited by 80 · cited 1×
“[68] Interference Interference score=0.”
Andrykowski, M. A., Donovan, K. A., & Jacobsen, P. B. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2008.03.015 · Cited by 77 · cited 1×
“Six studies included cancer patients undergoing cancer treatment, including chemotherapy, radiotherapy, and autologous stem cell transplantation; four of these provided data sufficient for us to calculate effect sizes for FSI severity items, frequency items, and the interference scale [4, 25, 42, 43].”
BackgroundSelf-citationFatigue after treatment for early stage breast cancer: A controlled comparison
Jacobsen, P. B., Donovan, K. A., Small, B. J., Jim, H. S., Munster, P. N., & Andrykowski, M. A. (2007) · Cancer · doi:10.1002/cncr.22993 · Cited by 74
Self-citationSiegel, S. D., Antoni, M. H., FLETCHER, M. A., Maher, K. J., Segota, M. C., & Klimas, N. G. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.03.001 · Cited by 65 · cited 1×
“While the FSI has been used predominantly to assess fatigue in cancer patients, results also were reported for persons with schizophrenia or schizoaffective disorder [31], chronic fatigue syndrome [67], and heart failure [23].”
ResultRogers, L. Q., Courneya, K. S., Robbins, K. T., Rao, K., Malone, J. P., Seiz, A., Reminger, S. L., Markwell, S. J., & Burra, V. (2008) · Head & Neck · doi:10.1002/hed.20873 · Cited by 59 · cited 7×
“Among the studies reporting associations with the CES-D, for example, correlation coefficients range from 0.34–0.76.”
MethodInfluentialPsychometric testing of three Chinese fatigue instruments in taiwan
Shun, S.-C., Beck, S. L., Pett, M. A., & Berry, P. H. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.02.011 · Cited by 58 · cited 4×
“Eight studies [15, 20, 21, 29, 30, 59, 65, 66] reported results based on modified approaches for scoring the FSI.”
MethodInfluentialFeasibility and Validity of a One-Item Fatigue Screen in a Thoracic Oncology Clinic
Temel, J. S., Pirl, W. F., Recklitis, C. J., Cashavelly, B. J., & Lynch, T. J. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31611-7 · Cited by 56 · cited 6×
“87) with the FACIT-Fatigue Scale [72], a scale for which higher scores represent lower levels of fatigue [77].”
MethodInfluentialFatigue in cancer patients treated with cytotoxic drugs
Hartvig, P., Aulin, J., Hugerth, M., Wallenberg, S., & Wagenius, G. (2006) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155206070774 · Cited by 56 · cited 6×
“These approaches included calculating a mean score across all four of the fatigue severity items [21], calculating a mean score across the most, least, and average fatigue severity items [20], creating a fatigue score ranging from 0–127 by summing the first 13 FSI items [59], and creating an index score with a value b…”
BackgroundMethodInfluentialFatigue and Quality of Life Following Radiotherapy for Breast Cancer: A Comparative Study
Hann, D. M., Jacobsen, P. B., Martin, S. C., Azzarello, L. M., & Greenberg, H. (1998) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/a:1026249702250 · Cited by 53 · cited 9×
“Among the studies reporting associations with the CES-D, for example, correlation coefficients range from 0.34–0.76.”
BackgroundMethodSelf-citationDahn, J. R., Penedo, F. J., Molton, I. R., Lopez, L., Schneiderman, N., & Antoni, M. H. (2005) · Urology · doi:10.1016/j.urology.2004.11.029 · Cited by 44 · cited 3×
“There were few studies of older cancer patients; only four reported a mean/median age greater than 65 years of age [16, 46, 52, 62].”
BackgroundFatigue With Systolic Heart Failure
Fink, A. M., Sullivan, S. L., Zerwic, J. J., & Piano, M. R. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181ae1e84 · Cited by 44 · cited 5×
“[23, 24] reported alpha coefficients ranging from 0.”
MethodResultInfluentialThe Effects of Group Exercise on Fatigue and Quality of Life During Cancer Treatment
Losito, J. M., Murphy, S. O., & Thomas, M. L. (2006) · Oncology nursing forum · doi:10.1188/06.onf.821-825 · Cited by 42 · cited 4×
“Five studies reported results in the context of nonpharmacological interventions designed to ameliorate symptoms that included fatigue [15, 22, 30, 51, 74].”
BackgroundMethodResultInfluentialA pilot examination of the impact of cancer patients' fatigue on their spousal caregivers
PASSIK, S. D., & KIRSH, K. L. (2005) · Palliative and Supportive Care · doi:10.1017/s1478951505050431 · Cited by 31 · cited 2×
“These approaches included calculating a mean score across all four of the fatigue severity items [21], calculating a mean score across the most, least, and average fatigue severity items [20], creating a fatigue score ranging from 0–127 by summing the first 13 FSI items [59], and creating an index score with a value b…”
MethodThe Effect Size Statistic: Useful in Health Outcomes Research ?
Hevey, D., & McGee, H. M. (1998) · Journal of Health Psychology · doi:10.1177/135910539800300201 · Cited by 29
Lai, Y., Shun, S., Hsiao, Y.-L., Chiou, J.-F., Wei, L.-L., Tsai, J.-T., & Kao, C.-Y. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-221 · Cited by 25 · cited 3×
“Hartvig et al. [48] Mean of severity, one frequency item, interference Losito et al. [ 50 ] Interference”
BackgroundMethodInfluentialCella, D. F., Viswanathan, H. N., Hays, R. D., Mendoza, T. R., Stein, K., Pasta, D. J., Foreman, A. J., Vadhan‐Raj, S., & Kallich, J. D. (2008) · Cancer · doi:10.1002/cncr.23698 · Cited by 20 · cited 1×
“Sample sizes in the identified publications ranged from a low of nine in a study to determine the feasibility of participating in a structured group exercise intervention among cancer patients undergoing chemotherapy [51] to a high of 1,756 in a study to develop a measure of fatigue and functional impairment in cancer…”
BackgroundFeasibility and Validity of a One-Item Fatigue Screen in a Thoracic Oncology Clinic
Temel, J. S., Pirl, W. F., Recklitis, C. J., et al. (2006) · Journal of Thoracic Oncology · doi:10.1097/01243894-200606000-00013 · Cited by 15
Shun, S., Beck, S. L., Pett, M. A., & Richardson, S. (2007) · The Oncologist · doi:10.1634/theoncologist.12-4-495 · Cited by 14 · cited 6×
“As shown in Table 3, FSI severity and frequency items and the interference scale have been shown to be positively correlated with the Profile of Mood States (POMS) Fatigue subscale [23, 24, 27], the Cancer Fatigue Scale [65], the Schwartz Cancer Fatigue Scale-Revised [65], the Global Rating Scale [ 66 ], and the Multi…”
BackgroundMethodInfluentialPhysical exercise for cytotoxic drug-induced fatigue
Hartvig, P., Aulin, J., Wallenberg, S., & Wagenius, G. (2006) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155206070776 · Cited by 12 · cited 5×
“[30] Interference Interference score range=0.”
MethodResultInfluentialThe rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Research works printed but not linked: 1
- Jacobsen PB, Azzarello LM, Hann DM (1999) Relation of catastrophizing to fatigue severity in women with breast cancer. Cancer Res Ther Control 8:155–164
Cited by
Bower, J. E., Ganz, P. A., Irwin, M. R., Kwan, L., Breen, E. C., & Cole, S. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1154 · Cited by 486
Mindfulness meditation for younger breast cancer survivors: A randomized controlled trial
Bower, J. E., Crosswell, A. D., Stanton, A. L., Crespi, C. M., Winston, D., Arevalo, J., Ma, J., Cole, S. W., & Ganz, P. A. (2015) · Cancer · doi:10.1002/cncr.29194 · Cited by 390
Yoga for persistent fatigue in breast cancer survivors: A randomized controlled trial
Bower, J. E., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., & Greendale, G. (2012) · Cancer · doi:10.1002/cncr.26702 · Cited by 352
“Fatigue interference with activities, mood, and enjoyment of life was assessed with the interference subscale of the FSI.(28,29) Finally, blood and saliva samples were collected for assessment of biologic functioning; the results from these assays still are pending and will be reported separately.”
MethodInfluentialUnderstanding mental fatigue and its detection: a comparative analysis of assessments and tools
Kunasegaran, K., Ismail, A. M. H., Ramasamy, S., Gnanou, J. V., Caszo, B. A., & Chen, P. L. (2023) · PeerJ · doi:10.7717/peerj.15744 · Cited by 219
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz, P. A., Bower, J. E., Kwan, L., Castellon, S. A., Silverman, D. H. S., Geist, C., Breen, E. C., Irwin, M. R., & Cole, S. W. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.015 · Cited by 140
“Fatigue was assessed using the Fatigue Symptom Inventory (FSI), a valid and reliable 14-item measure specifically designed to assess fatigue in cancer populations (Hann et al., 1998; Donovan et al., 2008; Donovan and Jacobsen, 2010).”
Method
Metadata
- Authors
- Donovan, K. A., & Jacobsen, P. B.
- Affiliations
- Moffitt Cancer Center (US)
- University of South Florida (US)
- Corresponding author
- Donovan, Kristine A.
- Venue
- Supportive Care in Cancer
- Published
- 2010-09-08
- Volume
- 19
- Issue
- 2
- Pages
- 169-185
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2110980660
- Cited by
- 94
- References
- 79
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 8 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 10 · 2015: 5 · 2014: 8 · 2013: 4 · 2012: 3
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Supportive Care in Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- fatigue measurement, psychometric properties, internal consistency, test-retest reliability, convergent validity, discriminant validity, sensitivity to change, cancer-related fatigue, chronic disease
- MeSH terms
- Fatigue, Female, Humans, Male, Neoplasms, Psychometrics, Severity of Illness Index, Reproducibility of Results, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.